SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-049161
Filing Date
2024-04-26
Accepted
2024-04-26 16:16:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A 2024_proxy_defa14a.htm DEFA14A 25359
2 GRAPHIC img162822738_0.jpg GRAPHIC 1527852
3 GRAPHIC img162822738_1.jpg GRAPHIC 147257
  Complete submission text file 0000950170-24-049161.txt   2332146
Mailing Address 321 HARRISON AVENUE BOSTON MA 02118
Business Address 321 HARRISON AVENUE BOSTON MA 02118 (617) 221-9059
Pyxis Oncology, Inc. (Filer) CIK: 0001782223 (see all company filings)

IRS No.: 831160910 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40881 | Film No.: 24883993
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)